Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
CGEN
#3584
Compugen Ltd. - Ordinary Shares
2.3
0
USD
-0.04%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-3.77%
Monthly Change
+13.30%
6 month change
+13.86%
Year Change
+42.86%
Previous Close
2.3
9
Open
2.3
0
Low
2.3
0
High
2.3
0
Volume
16
Markets
US Stock Market
Healthcare
Biotechnology
CGEN
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
83.68 M
86.43 M
86.62 M
89.24 M
89.54 M
94.55 M
94.55 M
Valuation ratios
Enterprise value
—
—
50.44 M
164.14 M
118.77 M
54.07 M
142 M
Price to earnings ratio
-32.73
-10.49
-1.82
-9.5
-9.56
4.03
6.47
Price to sales ratio
481.92
60.35
8.19
5.23
4.92
1.97
—
Price to cash flow ratio
34.03
15.92
1.78
4.87
2.76
4.54
7.3
Price to book ratio
8.05
3.39
0.79
2.67
2.49
1.4
2.25
Enterprise value to EBITDA ratio
—
—
-1.75
-13.46
-8.24
1.7
—
Profitability ratios
Return on assets %
-0.21
-0.26
-0.36
-0.15
-0.12
0.23
0.22
Return on equity %
-0.25
-0.32
-0.43
-0.29
-0.26
0.34
0.34
Return on invested capital %
-1 219
-1 175.45
-1 265.3
-13.27
-81.27
553.09
—
Gross margin %
97
88.67
87
94.01
71.54
87.29
—
Operating margin %
-1 574.8
-584.57
-471.65
-38.83
-53.44
43.05
—
EBITDA margin %
-1 497.6
-555.37
-384.97
-36.44
-51.7
43.7
—
Net margin %
-1 484.9
-570.05
-449.25
-56.05
-51.07
48.57
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
12.27
7.21
7.23
4.36
5.26
6.56
6.56
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.02
0.04
0.07
0.31
0.24
0.54
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.36
-0.27
-0.4
-0.41
0.55
0.34
0.34
EBIT per share
-0.4
-0.42
-0.41
-0.15
-0.17
0.33
—
EBITDA per share
-0.38
-0.4
-0.33
-0.14
-0.16
0.34
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
1.56
1.39
0.96
0.58
1.15
1.55
1.55
Net current asset value per share
1.62
1.46
1
1.31
1.18
1.58
1.58
Tangible book value per share
1.5
1.27
0.9
0.75
0.61
1.1
1.1
Working capital per share
1.49
1.26
0.86
1.01
0.96
1.34
1.34
Book value per share
1.5
1.27
0.9
0.75
0.61
1.1
1.1
News
Compugen Ltd. (CGEN) Q1 2026 Earnings Call Transcript
Compugen (CGEN) Reports Q1 Loss, Lags Revenue Estimates
BioXcel Therapeutics, Inc. (BTAI) Reports Q1 Loss, Lags Revenue Estimates
Adherex Technologies Inc. (FENC) Beats Q1 Earnings and Revenue Estimates
Janux Therapeutics, Inc. (JANX) Reports Q1 Loss, Lags Revenue Estimates
BioMarin Pharmaceutical (BMRN) Q1 Earnings Lag Estimates
Compugen at Leerink Global Healthcare Conference: Strategic Insights
Compugen Ltd. (CGEN) Q4 2025 Earnings Call Transcript
Morgan Stanley raises AstraZeneca stock price target on earnings growth
Compugen (CGEN) Beats Q4 Earnings and Revenue Estimates
Compugen earnings beat by $0.68, revenue topped estimates
Compugen stock jumps 5% on fourth quarter earnings beat